# Ketamine Interleaved With Electroconvulsive Therapy for Depression

> **NCT04082858** · PHASE1 · TERMINATED · sponsor: **St Patrick's Hospital, Ireland** · enrollment: 3 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT04082858
- **Lead sponsor:** St Patrick's Hospital, Ireland
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-06
- **Primary completion:** 2020-06-03
- **Final completion:** 2020-06-03
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Inadequate recruitment due to COVID-19
- **Last updated:** 2021-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04082858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04082858, "Ketamine Interleaved With Electroconvulsive Therapy for Depression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04082858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*